The results reported by Johnson et al. suggest that the toxicity of breast cancer radiotherapy can be reduced by scheduling patients for therapy based on their PER3 VNTR number and NOCT rs131116075 genotypes [64]. The gene discussed is PER3; the disease is breast carcinoma.